Originally published In Press as doi:10.1074/jbc.M109412200 on March 28, 2002
J. Biol. Chem., Vol. 277, Issue 23, 20423-20430, June 7, 2002
Cell Surface Targeting and Clustering Interactions between
Heterologously Expressed PSD-95 and the Shal Voltage-gated
Potassium Channel, Kv4.2*
Wei
Wong
§¶,
Evan W.
Newell
**,
Denis
G. M.
Jugloff
§,
Owen T.
Jones
§
, and
Lyanne C.
Schlichter
§
§§
From the
Division of Cellular and Molecular Biology,
Toronto Western Research Institute, University Health Network, Toronto,
Ontario M5T 2S8, and the § Department of Pharmacology and
the
Department of Physiology, University of Toronto,
Toronto, Ontario M5S 1A8, Canada
Received for publication, September 28, 2001, and in revised form, March 28, 2002
 |
ABSTRACT |
Kv4.2 is a voltage-gated potassium channel that
is critical in controlling the excitability of myocytes and neurons.
Processes that influence trafficking and surface distribution patterns
of Kv4.2 will affect its ability to contribute to cellular functions. The scaffolding/clustering protein PSD-95 regulates trafficking and
distribution of several receptors and Shaker family Kv
channels. We therefore investigated whether the C-terminal
valine-serine-alanine-leucine (VSAL) of Kv4.2 is a novel binding motif
for PSD-95. By using co-immunoprecipitation assays, we determined that
full-length Kv4.2 and PSD-95 interact when co-expressed in mammalian
cell lines. Mutation analysis in this heterologous expression system showed that the VSAL motif of Kv4.2 is necessary for PSD-95 binding. PSD-95 increased the surface expression of Kv4.2 protein and caused it
to cluster, as shown by deconvolution microscopy and biotinylation assays. Deleting the C-terminal VSAL motif of Kv4.2 eliminated these
effects, as did substituting a palmitoylation-deficient PSD-95 mutant.
In addition to these effects of PSD-95 on Kv4.2 distribution, the
channel itself promoted redistribution of PSD-95 to the cell surface in
the heterologous expression system. This work represents the first
evidence that a member of the Shal subfamily of Kv channels
can bind to PSD-95, with functional consequences.
 |
INTRODUCTION |
The influence that voltage-gated ion channels exert on the
integrative physiology of excitable cells is determined by the inherent
biophysical properties of the channels and their cell surface
distribution. Kv4.2 is a fast transient (A-type) voltage-gated potassium (Kv)1 channel of
the Shal subfamily that is found in heart and neurons (1).
In myocytes, Kv4.2 is a major component of the Ito current,
which is crucial for recovery from the QT interval and for
repolarization (2). In neurons of the central nervous system, Kv4.2 is
expressed primarily somatodendritically (3, 4), where its concentration
at postsynaptic sites may affect the back propagation of action
potentials (5) and may therefore modulate long term potentiation at
synapses (6). In contrast, Kv1.4, a Kv channel of the Shaker
subfamily, is primarily expressed on axons (3, 4). Its positioning
along the axon and at presynaptic sites (7-9) is thought to regulate
the efficiency of action potential propagation (10) and to control
neurotransmitter release (11). It is therefore crucial to understand
the basis for the specialized distributions of Kv channels in order to
fully understand their roles in neuronal excitability. The mechanisms
that specify ion channel distributions are not well known and likely
differ between those that determine localization in sub-domains of
cells (e.g. axon, soma, and dendrite) versus
lateral organization at the membrane, such as within channel clusters.
Post-synaptic density 95 (PSD-95) is a membrane-associated guanylate
kinase that helps localize and cluster numerous proteins. Kv1.4 and
other Kv1 members are among the best known examples of in
vitro ion channel clustering by PSD-95, but this is the only
subfamily of Kv channels known to interact with PSD-95 (12, 13).
PSD-95-mediated clustering has profound effects on the trafficking of
Kv1 channels: it promotes surface expression (14) and suppresses
endocytosis (15). Because clusters of PSD-95 with Kv1 channels are
apparently immobile (16), this interaction may contribute to the
polarized surface distribution exhibited by many Kv1 channels. Although
several PSD-95-binding motifs begin with a glutamate residue, such as
Kv1.4 (ETDV) and Kv1.5 (ETDL), several Kv1 channels (e.g.
Kv1.1, Kv1.2, and Kv1.3) associate with PSD-95 through an alternate
binding motif in which the glutamate residue is replaced by a
hydrophobic amino acid (17).
Kv4.2 has a C-terminal Val-Ser-Ala-Leu (VSAL) that is very similar to
the hydrophobic amino acid (T/S)XV motif; thus, we asked whether Kv4.2 associates with PSD-95 and whether VSAL represents a
binding motif. We show, through co-immunoprecipitation and mutational analysis, that Kv4.2 protein does bind to PSD-95 in a heterologous expression system and that this interaction requires the VSAL motif.
The interaction had physiological consequences for both Kv4.2 and
PSD-95 protein distributions. PSD-95 increased the surface expression
of Kv4.2 protein and caused it to cluster, as shown by deconvolution
microscopy and biotinylation assays, and these effects required both
the VSAL motif in Kv4.2 and the palmitoylation motif in PSD-95.
Conversely, interaction with Kv4.2 increased the surface expression of
PSD-95. Thus, by affecting the amount and location of channel protein,
the PSD-95 interaction with Kv4.2 could affect the integrated
electrophysiological properties of neurons.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Myc-tagged PSD-95 in the expression vector,
pGW1-CMV, was a generous gift from Dr. Morgan Sheng (Harvard
University, Boston, MA). C3,5S-PSD-95, the palmitoylation-deficient
PSD-95 mutant in which the cysteine residues at positions 3 and 5 are
replaced by serine residues, was described previously (15).
Oligonucleotide primers were synthesized by ACGT Inc. (Toronto,
Ontario, Canada). All chemicals were obtained from Sigma unless
otherwise indicated.
Preparing the Kv4.2 Mammalian Expression Constructs--
Kv4.2
constructs in mammalian expression vectors were prepared using PCR with
first-strand cDNA synthesized from rat hippocampus as template
(Fast Track, Stratagene, La Jolla, CA). We first PCR-amplified a
FLAG-tagged, wild-type cDNA (which we call Kv4.2) that included residues 1-630 (18), using the primers 5'
ATGGACTACAAGGACGACGATGACAAGGCAGCCGGTGTTGCAGCATGG 3' (forward; also
encodes the FLAG epitope after the start codon) and 5'
TTACAAAGCAGACACCCTGAC 3' (reverse). This was ligated into the multiple
cloning site of pCRII (Invitrogen, Carlsbad, CA) and then excised with
NsiI/XhoI for ligation into the
PstI/XhoI sites of pSVK3 (Amersham Biosciences)
and pBK-CMV (Stratagene). Expression of Kv4.2 in pBK-CMV was examined
by immunoblotting. Then, to facilitate studies of channel localization
using fluorescence microscopy, an N-terminal fusion of the wild-type
Kv4.2 construct to enhanced cyan fluorescent protein, ECFP (C-Kv4.2),
was prepared by excising the coding sequence from the pSKV3 clone with
EagI and ligating it into the Bsp120 I site of
pECFP-C1 (CLONTECH, Palo Alto, CA). By using
C-Kv4.2 cDNA as the template, a Kv4.2 deletion mutant lacking the
four C-terminal amino acids (VSAL) was prepared by Pfu
(Stratagene) PCR using the primers 5'
TTTGAATTCTATGGCAGCCGGTGTTGCAGCATGG 3' (forward, encodes an
EcoRI site before the start codon) and 5'
TTTGGGCCCTTTTTACCTGACGATGTTTCCTCC 3' (reverse, encodes an
ApaI site after the stop codon). This cDNA was ligated
into the EcoRI and ApaI sites of pcDNA3.1 or
pECFP-C1 to produce the Kv4.2 deletion mutant (Kv4.2
VSAL) and the
ECFP-tagged Kv4.2 deletion mutant (C-Kv4.2
VSAL). For patch clamp
analysis, we used a full-length Kv4.2 clone in pBiG
(CLONTECH) containing a Kozak consensus sequence before the start codon (generously provided by Dr. P. Backx, University of Toronto). From this clone, a Kv4.2 mutant lacking the VSAL motif was
generated with Pfu PCR, using the forward primer 5' TTTGAATTCTCCGCCATGGCAGCCGGTG 3' (encodes an EcoRI site and
Kozak consensus sequence before the start codon), and the same reverse primer was used to create the deletion mutant (above).
The identities of all constructs used were verified through dideoxy
sequencing (York University Sequencing Facility, and the University
Health Network Research DNA Sequencing Facility, Toronto, Ontario, Canada).
Cell Culture and Transfection--
We used three cell lines for
heterologous expression. HEK293T cells were formerly called tsA201 and
are HEK293 cells that constitutively express the SV40 large T antigen
to allow plasmid replication using the SV40 origin. Although they are
apparently the same cells, we will follow the nomenclature used by the
laboratories from which we obtained them. HEK293T cells (from Dr. D. Papazian, UCLA, CA) were maintained and transfected as described
previously (19), but using only 0.5 µg of total DNA. This low amount
of DNA was transfected because HEK293T cells were used for indirect immunofluorescence, and it was easier to discern surface
versus subcellular staining when less protein was expressed.
tsA201 cells (from Dr. P. Backx) were mainly used for biochemical
studies, where it was advantageous to increase the amount of protein
expressed. They were grown at 37 °C, 95% O2, 5%
CO2 in Dulbecco's modified essential medium (University
Health Network Sera and Media Services, Toronto) supplemented with 10%
fetal bovine serum, 10 µg/ml penicillin, and 10 units/ml streptomycin
(all supplements obtained from Invitrogen). The tsA201 cells were
seeded at 4.5 × 105 cells/cm2 and then
transfected the next day with 2.5-10 µg of total DNA, using the
calcium phosphate precipitation method (20). For fluorescence imaging,
the cells were replated the following day on collagen- and
poly-L-lysine-coated coverslips and used 36-48 h after transfection.
For heterologous expression for electrophysiology experiments, we used
CHO cells, which were maintained as described previously (21). CHO
cells were seeded at 2.07 × 105 cells/cm2
and then transfected on the following day with 2 µg of total DNA plus
0.2 µg of pEGFP-C1 (CLONTECH) using FuGENE 6 (Roche Molecular Biochemicals). The cells were replated the day after
transfection on poly-L-lysine-coated coverslips, and
EGFP-positive cells were patch clamped 36-48 h after transfection, as
described below.
Electrophysiology--
Whole-cell patch clamp recordings (15,
22) were used to assess the functional expression of Kv4.2 (with Kozak
sequence), Kv4.2
VSAL (with Kozak sequence), and C-Kv4.2
(ECFP-tagged) in transfected CHO cells. The pipette solution (300-310
mosM) contained (in mM) 140 KCl, 5 EGTA
(potassium salt), 4 MgATP, 1 MgCl2, and 10 HEPES, adjusted
to pH 7.2 with KOH. The bath solution (310-320 mosM)
contained 140 NaCl, 10 glucose, 5.4 KCl, 2 CaCl2, 1 MgCl2, and 10 HEPES, adjusted with NaOH to pH 7.4. All
recordings were made at room temperature.
Co-immunoprecipitation--
tsA201 cells were co-transfected
with Myc-tagged PSD-95 and one of the Kv4.2 channel constructs, so that
we could immunoprecipitate PSD-95-containing complexes from these cells
with an antibody directed against Myc. The Kv4.2 antibody was not
effective for immunoprecipitation; thus, the reverse experiment could
not be done. The cells were lysed with 500 µl of Nonidet P-40 co-IP
buffer (1% Nonidet P-40, 100 mM NaCl, 20 mM
Tris, pH 8.5, and 1 mM EDTA) supplemented with protease
inhibitors (0.1 mM phenylmethylsulfonyl fluoride, 1 µg/ml
aprotinin, 1 µg/ml leupeptin, and 1 µM pepstatin A).
The lysates were incubated with co-IP buffer for 20 min on ice and then
clarified by centrifugation, and a small aliquot was reserved for
direct immunoblotting. The remaining sample was pre-cleared by a 3-h
incubation with protein A/G-agarose (Oncogene Science, Cambridge, MA),
which was also used to capture antibody-protein complexes. The
immunoprecipitates were boiled in 2× SDS gel-loading buffer prior to
SDS-PAGE.
SDS-PAGE and Immunoblot Analysis--
A polyclonal antibody was
prepared against a peptide (Vetrogen, London, Ontario, Canada)
corresponding with residues 23-43 of Kv4.2 (GenBankTM
accession number S64320) with an additional C-terminal cysteine for
coupling to keyhole limpet hemocyanin (Pierce). After confirming the
identity of the peptide by amino acid analysis and mass spectroscopy, and cross-linking it to keyhole limpet hemocyanin with
m-maleimidobenzoyl-N-hydroxysulfosuccinimide ester (Pierce), the conjugated peptide was purified by dialysis against
phosphate-buffered saline (PBS) and injected into New Zealand White
rabbits (Division of Comparative Medicine, University of Toronto,
Toronto, Ontario, Canada). Next, antisera were collected from the
immunized rabbits and the IgG fraction enriched by protein A affinity
chromatography (MAPS kit, Bio-Rad). This antibody has been extensively
used to detect Kv4.2 in immunoblots of heart tissue (23, 24), brain
(23, 25), and transfected cells (25), as well as in
immunohistochemistry of heart tissue (24).
Protein samples were prepared, electrophoresed, and transferred to
nitrocellulose as described previously (26). The nitrocellulose membranes were incubated overnight at 4 °C with the Kv4.2 polyclonal antibody at 1:1000. Immunoreactivity was detected by incubating the
membrane with goat anti-rabbit conjugated to horseradish peroxidase (Cedarlane Laboratories, Hornby, Ontario, Canada; 1:4000), followed by
enhanced chemiluminescence (ECL; Amersham Biosciences). Quantification was done with a GS-670 imaging densitometer and Molecular Analyst 1.1 (Bio-Rad).
Biotinylation of Cell-surface Proteins--
Kv4.2 contains two
putative extracellular lysine residues (18); thus, surface and
intracellular channel protein can be differentiated using
cell-impermeant biotinylating reagents that target lysine residues.
Before transfection, tsA201 cells were plated on
poly-L-lysine-treated (Sigma) 6-well plates. Biotinylation
of cell-surface proteins was performed essentially as described
previously (27), except that cells were biotinylated with 1.5 mg of
sulfo-NHS-LC-biotin per 35-mm well (Pierce). Biotinylated cell
membranes were incubated in 50 µl of SDS lysis buffer (1% SDS, 20 mM Tris, pH 8.0, 50 mM NaCl, 5 mM
EDTA) for 10 min at 65 °C. The cell extracts were then diluted with
4 volumes of Triton lysis buffer (1% Triton, 20 mM Tris,
pH 8.0, 50 mM NaCl, 5 mM EDTA) and incubated
for a further 60 min on ice before pelleting insoluble materials.
Biotinylated proteins were isolated and immunoblotted as described
previously (28), except that Neutravidin Ultralink (Pierce) was used to affinity purify the biotinylated proteins.
Fluorescence Imaging--
To assess Kv4.2 protein localization
and clustering, live tsA201 cells were washed with Dulbecco's PBS (139 mM NaCl, 2.7 mM KCl, 8.8 mM
Na2HPO4, 1.48 mM
KH2PO4) and mounted on glass slides. Cells were
imaged using a Zeiss Axioplan 2 Imaging microscope (Carl Zeiss, Inc.,
Thornwood, NY) equipped with a digital camera (Zeiss AxioCam) and a
100× oil-immersion objective. Image stacks spanning the full
z axis of the cell (with images spaced 200 nm apart) or
spanning 0.5
2 µm (with images spaced 25 nm apart) were collected
for each transfection condition. All z image stacks were
deconvolved in AxioVision 4.0 (Carl Zeiss, Inc.) using the constrained
iterative algorithm.
Localization of Kv4.2 and PSD-95 proteins was assessed by indirect
immunofluorescent detection of ECFP-tagged channels and Myc-tagged
PSD-95 (29). Cells were washed with PBS, fixed with 4%
paraformaldehyde, and permeabilized with 0.1% Triton. Nonspecific binding was blocked with 3% heat-inactivated goat serum and 0.1% bovine serum albumin in PBS. Cells were then incubated with 1:2000 anti-GFP (Molecular Probes) (to detect ECFP-tagged channels) and/or 1:200 anti-Myc (to detect the tagged PSD-95) for 1 h at room
temperature. This was followed by a 1-h incubation at room temperature
with goat anti-rabbit conjugated to Alexa Fluor 488 (1:1000) and goat anti-mouse conjugated to Alexa Fluor 594 (1:200) in 0.1% bovine serum
albumin in PBS. The coverslips were mounted in Slowfade (Molecular
Probes) and imaged as above. Images were overlaid in AxioVision
4.0.
Statistical Tests--
Student's t test was used to
analyze electrophysiological and immunoblotting data. Percentages (from
the biotinylation cell surface assay) were subjected to arcsin
transformation to produce data with a normal distribution (30) prior to
statistical analysis using the Student's t test. Values of
p < 0.05 were considered significant.
 |
RESULTS |
Heterologously Expressed Full-length, Deletion Mutant, and
ECFP-tagged Kv4.2 Constructs Form Functional Channels--
Because
tsA201 cells express an endogenous potassium current (31) that is not
Kv4.2 (see Refs. 32 and 33; see also Fig. 2A), we used CHO
cells for electrophysiological analysis. Consistent with previous
reports (31, 32), no voltage-gated currents were detected in whole-cell
recordings from cells transfected with pEGFP-C1 alone
(mock-transfected; n = 6) (Fig.
1A). However, within 48 h
after Kv4.2 cDNA was transiently transfected, K+
currents appeared (Fig. 1B), which were large,
depolarization-activated, rapidly inactivating and similar to
previously described (32, 33) Kv4.2 currents expressed in heterologous
systems. Current densities ranged from 12 to 105 pA/pF
(n = 5). As demonstrated previously (34, 35),
inactivation was best described as the sum of two inactivation time
constants: a fast component accounting for 83 ± 1% of
inactivation (
fast = 17.7 ± 1.5 ms at +60 mV) and
a slow component (
slow = 435 ± 114 ms at +60 mV)
(all error values are S.E. and all tests are Student's t
test, unless otherwise indicated). Cells co-transfected with Kv4.2 and
PSD-95 produced currents with similar characteristics to cells
expressing Kv4.2 alone (data not shown), with a comparable range of
current densities (21-81 pA/pF, n = 7;
p > 0.5). PSD-95 did not alter the inactivation kinetics (
fast = 19.2 ± 3.1 ms at +60 mV,
p > 0.5;
slow = 296 ± 104 ms at
+60 mV, p > 0.2) or the contribution of the fast
component to inactivation (81 ± 2%, p > 0.2).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 1.
Heterologously expressed Kv4.2 forms
functional channels. K+ currents in CHO cells were
elicited by voltage clamp steps delivered at 10-mV increments from a
holding potential of 70 mV (A, inset). Each
voltage step was 300 ms long, with an inter-pulse interval of 20 s
to allow recovery from inactivation. Representative traces are from
mock-transfected cells (A), or cells transfected with Kv4.2
(with Kozak sequence) (B), Kv4.2 VSAL (with Kozak
sequence) (C), or C-Kv4.2 (D). Kv4.2 and C-Kv4.2
are full-length and contain the VSAL motif but differ in the presence
of an N-terminal ECFP tag on C-Kv4.2. This tag was added to assist in
localizing Kv4.2 channels in living cells (see Fig. 5). Kv4.2 VSAL
lacks the last four amino acids at the C terminus. The inset
to B shows a Kv4.2-expressing cell before (pre-treatment)
and 10 min after perfusing the bath with 20 µM
quinidine.
|
|
Cells transfected with Kv4.2
VSAL expressed a current that resembled
the wild-type current (Fig. 1C) with a current density range
of 4-56 pA/pF (n = 4), indicating that Kv4.2 channels
lacking the C-terminal VSAL motif form functional channels on the cell surface. Deletion of the VSAL motif did not alter the time constants of
inactivation (
fast = 24.0 ± 2.6 ms at +60 mV,
p > 0.2;
slow = 441 ± 145 ms at
+60 mV, p > 0.5) or the contribution of the fast
component of inactivation (81 ± 9%; p > 0.5).
Transfection of C-Kv4.2 (ECFP-tagged) into CHO cells produced
K+ currents (Fig. 1D) ranging from 6 to 90 pA/pF
(n = 4); thus, adding the ECFP tag to the N terminus of
Kv4.2 does not prevent formation of functional channels. One clear
difference was that ECFP-tagged Kv4.2 inactivated more slowly than
Kv4.2 current: only one inactivation time constant could be fit
(
= 224 ± 35 ms at +60 mV). This effect of ECFP is not
surprising because the fast component of inactivation of
Shal family K+ channels involves concerted
actions of the N- and C-terminal domains (34), interactions that could
be impeded by a bulky N-terminal tag. Similarly two proteins (KChIP and
frequenin) were recently shown to bind to the N terminus of Kv4.2 and
enhance the slow component of inactivation (35, 36).
Kv4.2 channels are blocked by quinidine, which reduces the peak current
and accelerates the apparent inactivation rate (37). An application of
20 µM quinidine reduced the peak Kv4.2 current from 1200 to 295 pA at +60 mV (75% reduction) and reduced the fast time constant
of inactivation to 4.6 ms (Fig. 1B, inset).
Kv4.2 Binds to PSD-95; the VSAL Motif Is Necessary--
The
polyclonal anti-Kv4.2 antibody we made has been used in other studies
(23-25); nevertheless, we confirmed its performance in our system. The
antibody recognized a single ~70-kDa band in tsA201 cells that were
transfected with the full-length channel (Fig.
2A, lane 5). The
size is consistent with both the predicted (71 kDa) and previously
observed molecular weight of Kv4.2 (18, 36). Further evidence for
antibody specificity is the lack of immunoreactive bands in lysates
from mock-transfected cells or from cells expressing vector alone
(lanes 1-4), which also means that the endogenous
K+ channel (mentioned above) is not Kv4.2. Pre-incubating
the antibody with the antigenic peptide eliminated all immunoreactive
bands (lanes 9-12). We created several cDNA constructs
to assess the role of the C-terminal VSAL motif in its interaction with
PSD-95. The deletion constructs, Kv4.2
VSAL and C-Kv4.2
VSAL, lack
the VSAL motif at the C terminus. Lysates from tsA201 cells that had been transfected with the different constructs were immunoblotted with
the Kv4.2 antibody to verify that the different proteins were well
expressed. The antibody recognized one major band for each construct:
at about 96, 68, and 94 kDa for C-Kv4.2, Kv4.2
VSAL, and
C-Kv4.2
VSAL, respectively (Fig.
3A, lanes 5-8).
Again, the product sizes are close to those expected and observed for
an ECFP-tagged Kv4.2 fusion protein (38) and the slightly reduced size
of the VSAL deletion mutant. As a further control, we determined the
linear detection range of the antibody before quantifying differences
in channel expression at the cell surface (below). Western analysis
showed that the band density was a linear function of protein loaded
between 2.5 and 20 µg for both wild-type and ECFP-tagged constructs
(Fig. 2B).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 2.
The Kv4.2 antibody recognizes all the Kv4.2
constructs used. A, in lysates from transfected tsA201
cells, the Kv4.2 antibody recognized bands of about 70 kDa for Kv4.2
(lane 5), 68 kDa for Kv4.2 VSAL (lane 6), 96 kDa for C-Kv4.2 (lane 7), and 94 kDa for C-Kv4.2 VSAL
(lane 8). Pre-incubating the antibody with the Kv4.2
antigenic peptide eliminated these bands (lanes 9-12).
Immunoreactive bands were also absent in mock-transfected cells
(lane 1) or cells transfected only with the vectors, pBK-CMV
(lane 2), pcDNA3.1 (lane 3), or pBK-CMV
(lane 4). B, determining the linear range of
labeling and detection by the Kv4.2 antibody. The insets
show Western blots (WB) for a range of protein amounts
loaded onto the gel (2.5, 5, 10, and 20 µg) for both the wild-type
(Kv4.2) and ECFP-tagged constructs (C-Kv4.2). The graph
shows that densitometry readings were a linear function of protein
loaded between 2.5 and 20 µg (95% confidence intervals are indicated
by broken lines).
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 3.
Kv4.2 co-immunoprecipitates with PSD-95;
deleting VSAL eliminates the interaction. Proteins were
immunoprecipitated (IP) with Myc antibody from lysates of
cells co-expressing Myc-tagged PSD-95 and either C-Kv4.2 or
C-Kv4.2 VSAL and were probed with the Kv4.2 antibody through Western
blotting (WB). Full-length C-Kv4.2 was immunoprecipitated in
the presence of Myc antibody (2nd lane) but not in its
absence (3rd lane). In contrast, little or no deletion
mutant (C-Kv4.2 VSAL) was immunoprecipitated by the Myc antibody
(5th lane). L, lysate.
|
|
To assess whether Kv4.2 co-immunoprecipitates with PSD-95, full-length
constructs of C-Kv4.2, or the VSAL-lacking C-Kv4.2
VSAL were
co-expressed with Myc-tagged PSD-95 in tsA201 cells. Lysates prepared
from these cells were incubated with an antibody directed against Myc,
and the precipitates were probed with Kv4.2 antibody. Anti-Myc
immunoprecipitated C-Kv4.2 (Fig. 3, lane 2),
although omitting the Myc antibody eliminated the Kv4.2 band
(lane 3), thus confirming that the channel did not bind
nonspecifically to the agarose beads. The Kv4.2 mutant lacking the
C-terminal VSAL motif (C-Kv4.2
VSAL) did not immunoprecipitate with
Myc antibody (lane 5). The differential ability of PSD-95 to
immunoprecipitate C-Kv4.2 and C-Kv4.2
VSAL was not because of
differences in protein expression, since direct immunoblotting of
lysates from transfected cells revealed robust expression (lanes
1 and 4). Collectively, these results indicate that the
VSAL motif is necessary for Kv4.2 binding to PSD-95.
PSD-95 Increases the Cell Surface Expression of Kv4.2
Protein--
tsA201 cells were transfected with Kv4.2 or C-Kv4.2, with
or without PSD-95 co-transfection. A cell-impermeant biotinylating reagent that modifies extracellular lysine residues was used to label
cell-surface proteins, which were then affinity-purified on Neutravidin
beads. Western blots of cell lysates were probed with the Kv4.2
antibody to monitor the total amount of Kv4.2 construct expressed.
Precipitates were probed with the Kv4.2 antibody on the same blot as
the lysates to obtain the biotinylated fraction of Kv4.2 (Fig.
4A). The proportion of
biotinylated Kv channel was calculated by expressing each band density
in the biotinylated fraction as a percentage of the band density in the
corresponding lysate (i.e. total protein). When the amounts
of biotinylated Kv4.2 and C-Kv4.2 in the presence or absence of PSD-95
were compared (Fig. 4B), PSD-95 significantly increased the
biotinylated fraction by 2.4-fold for Kv4.2 (n = 3) and
1.4-fold for C-Kv4.2 (p < 0.05). Because only surface
channels become biotinylated, PSD-95 increased the surface expression
of Kv4.2. Patch clamp recordings did not reveal a significant increase
in Kv4.2 current when co-transfected with PSD-95; however, this is not
surprising because variability in transiently transfected Kv4.2
currents is large.2
Biochemical assays, such as cell surface biotinylation, performed on
populations of cells provide a better indication of average changes in
localization.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 4.
PSD-95 increases the cell surface expression
of Kv4.2 protein. A biotinylation assay was used to measure the
surface fraction of channel protein (see "Experimental
Procedures"), and representative Western blots are shown
(A and C). For each sample, labeled proteins were
precipitated with Neutravidin beads from 20 µg of total protein in
cell lysates and then immunoblotted with the Kv4.2 antibody to measure
the biotinylated protein. Total cellular expression of Kv4.2 protein
was assessed by directly immunoblotting 2.5 µg of each lysate, which
was one-eighth of the amount of protein added to the beads. These
protein amounts were chosen because they were within the linear range
of the Kv4.2 antibody (see Fig. 2B). A,
upper panel, representative Western blots from biotinylation
assays using tsA201 cells transfected with full-length Kv4.2 alone
(shaded bars) or together with PSD-95 (open
bars). Lower panel, representative Western blots from
biotinylation assays using cells transfected with ECFP-tagged Kv4.2
(C-Kv4.2) alone (shaded bars) or with PSD-95 (open
bars). B, summary of experiments like those in
A, using the same open and shaded bar
markings. The biotinylated proportion was calculated by expressing the
intensities of the Kv4.2 bands in the precipitates as a fraction of
those in the corresponding cell lysates. Each value represents the
mean ± S.E. of the number of experiments from different
transfected cell batches indicated on each bar. Student's t
test (after arcsin transformation) indicates values that differ at the
p < 0.05 level. C, representative Western
blots from biotinylation assays using cells co-transfected with the
ECFP-tagged Kv4.2 (C-Kv4.2) and the palmitoylation-deficient PSD-95
mutant (C3,5S-PSD-95) (hatched bars), or with the
ECFP-tagged Kv4.2 deletion mutant (C-Kv4.2 VSAL) and PSD-95
(shaded bars). D, summary of experiments in
part C. Each value represents the mean ± S.E. of three
experiments from different transfected cell batches. None of the values
differ from each other at the p < 0.05 level
(Student's t test after arcsin transformation).
|
|
We next investigated regions of Kv4.2 and PSD-95 that are likely to
mediate the observed increase in Kv4.2 surface expression. Cell surface
biotinylation was examined for cells co-expressing the deletion mutant
(C-Kv4.2
VSAL) plus wild-type PSD-95 or full-length Kv4.2 (C-Kv4.2)
plus a palmitoylation-deficient PSD-95 mutant, C3,5S-PSD-95 (Fig.
4C). This PSD-95 mutant can bind to, but not cluster, other
Kv channels (15, 29). Unlike wild-type PSD-95, the
palmitoylation-deficient mutant did not significantly increase the
proportion of full-length Kv4.2 on the cell surface (Fig. 4D) (p > 0.05, Student's t
test). Wild-type PSD-95 failed to increase the surface fraction of the
Kv4.2 mutant that lacked the putative PSD-95-binding motif
(C-Kv4.2
VSAL), when compared with full-length Kv4.2 alone (Fig.
4D) (p > 0.2). The surface expression of
Kv4.2 full-length channel in the presence of PSD-95 was significantly higher than the amount of Kv4.2
VSAL (C-Kv4.2 plus PSD-95, 13.5 ± 1.0%; C-Kv4.2
VSAL plus PSD-95, 8.3 ± 0.7%;
p < 0.05). Thus, PSD-95 binding and clustering appear
to be required for the increased surface expression of Kv4.2. Total
channel protein levels did not differ between the constructs or
transfection combinations, as indicated by the intensities of Kv4.2
immunoreactive bands in cell lysates (bands marked "total";
p > 0.05).
The specificity of the biotin-Neutravidin interaction was confirmed by
incubating lysates of cells transfected with Kv4.2 constructs but not
exposed to sulfo-NHS-LC-biotin; immunoreactive bands were absent after
affinity precipitation with Neutravidin beads (data not shown). The
high proportion of non-biotinylated channel protein we observed is
consistent with the large intracellular fraction seen from our imaging
data (below) and in earlier studies (22, 36). This distribution might
result from examining transient channel overexpression at a relatively
short time after transfection (48 h in our study).
Protein Domains Involved in Kv4.2 Surface Expression and Clustering
by PSD-95--
Live, transfected tsA201 cells were imaged by
exploiting the fluorescent ECFP-tagged Kv4.2 protein in order to
monitor channel protein distribution without potential fixation
artifacts. In cells expressing C-Kv4.2 alone, there was considerable
channel protein in an internal reticular network with some fluorescence present at the outer cell margins (Fig.
5A; representative of 34 cells). Some cells had highly fluorescent patches in the perinuclear region, as in Fig. 5D. Kv4.2 was reported previously (22,
36, 39) to be mainly on internal membranes, with a circle of strong fluorescence around the nucleus, in contrast to the discrete "hot spots" that we observed. PSD-95 co-expression (Fig. 5B;
representative of 40 cells) resulted in clustering of the channel
protein and good expression on the cell surface in about 50% of the
cells imaged. This clustering did not occur when C-Kv4.2 was
co-expressed with the palmitoylation-deficient PSD-95 mutant (Fig.
5C; representative of 24 cells); instead, considerable
fluorescence was present on intracellular compartments, similar to
cells expressing C-Kv4.2 alone. Therefore, eliminating the
palmitoylation sites on PSD-95 prevented it from clustering and
recruiting Kv4.2 to the cell surface. PSD-95 did not cluster the
VSAL-lacking Kv4.2 protein (Fig. 5D; representative of 26 cells), and the channel proteins were largely expressed on internal
membranes. Thus, binding of Kv4.2 to PSD-95 through the VSAL motif
appears to facilitate both clustering and recruitment of the channel to
the cell surface.

View larger version (80K):
[in this window]
[in a new window]
|
Fig. 5.
Protein domains involved in Kv4.2 surface
expression and clustering by PSD-95. Fluorescence microscopy of
live, transfected tsA201 cells using the ECFP tag on the Kv4.2 protein
and deconvolution deblurring. Imaged z stacks were
acquired from cells transfected with C-Kv4.2
(A), C-Kv4.2 plus PSD-95 (B), C-Kv4.2 plus
C3,5S-PSD-95 (C), C-Kv4.2 VSAL plus PSD-95 (D),
ECFP (E), or salmon sperm DNA (mock-transfected)
(F). The z stacks were deconvolved and a single
image was selected for presentation (scale bars, 5 µm).
ECFP-tagged full-length Kv4.2 alone, or in the presence of the
palmitoylation-deficient PSD-95, displayed significant localization on
internal membranes, as did the VSAL deletion mutant, even in the
presence of PSD-95. In contrast, C-Kv4.2 exhibited considerable surface
expression in the presence of PSD-95 and was clustered (some clusters
marked by arrowheads). When ECFP was expressed alone
(E) the fluorescence was distributed throughout the cell,
whereas mock-transfected cells (F) did not fluoresce.
|
|
Kv4.2 Promotes PSD-95 Redistribution to the Cell
Surface--
Because the localization of PSD-95 can be affected by
other interacting proteins (see "Discussion"), we asked whether
Kv4.2 could serve this function. Immunocytochemistry was conducted on fixed transfected HEK293T cells using anti-Myc to detect PSD-95 and
anti-GFP to detect C-Kv4.2, C-Kv4.2
VSAL, or ECFP. We amplified the
fluorescent signal from the ECFP-tagged channels by using anti-GFP and
a fluorescent secondary antibody in order to match the intensity of the
PSD-95 signal. Formaldehyde fixation and permeabilization were required
in order to label the intracellular epitopes on PSD-95 and Kv4.2, and
were performed according to standard procedures (29). PSD-95 was
diffusely distributed throughout the cell when transfected alone (Fig.
6A). Cells expressing only C-Kv4.2 exhibited extensive labeling of internal membranes (Fig. 6B). When PSD-95 and C-Kv4.2 were co-transfected, both
proteins were well expressed at the cell surface (Fig.
6C, arrowheads). This redistribution did not
occur when the VSAL motif was removed from Kv4.2 (Fig. 6D).
Recruitment of PSD-95 to the surface membrane did not result from the
ECFP used to tag the Kv4.2 protein because, when co-transfected with
the pECFP vector (Fig. 6E), PSD-95 displayed a diffuse
distribution similar to that seen for PSD-95 alone (Fig. 6A).

View larger version (79K):
[in this window]
[in a new window]
|
Fig. 6.
Kv4.2 promotes PSD-95 redistribution to the
cell surface. Immunofluorescent microscopy of fixed, transfected
HEK293T cells using deconvolution deblurring, as in Fig 5. Anti-Myc and
an Alexa Fluor 594-conjugated secondary antibody were used to detect
PSD-95 (top panels). Anti-GFP and an Alexa Fluor
488-conjugated secondary antibody were used to detect C-Kv4.2,
C-Kv4.2 VSAL, or ECFP (bottom panels). Imaged z
stacks were acquired from cells transfected with PSD-95 (A)
or C-Kv4.2 alone (B), PSD-95 plus C-Kv4.2 (C),
PSD-95 plus C-Kv4.2 VSAL (D), and PSD-95 plus ECFP
(E). The z stacks were deconvolved, and a single
image was selected for presentation (scale bars, 5 µm). PSD-95 displayed a diffuse cytoplasmic distribution when
transfected alone (A) or when co-transfected with the Kv4.2
VSAL deletion mutant (D) or with ECFP (E).
ECFP-tagged Kv4.2 (C-Kv.42) exhibited significant localization on
internal membranes when expressed alone (B), as did the VSAL
deletion mutant, even in the presence of PSD-95 (D). In
contrast, both PSD-95 and C-Kv4.2 exhibited considerable surface
expression when co-expressed (C,
arrowheads).
|
|
We noted some differences between cells imaged "live" and those
fixed and permeabilized. The Kv4.2 clustering observed in live cells
was not apparent in fixed cells (compare Fig. 5B with 6C, lower panel). One possible reason is that the
fluorescence signal from live cells was low, making the small clusters
easier to discriminate. In contrast, when co-labeling fixed cells, the fluorescence signal was amplified using antibodies with high intensity Alexa fluorophores, which will produce more overlap in the fluorescence signal. Also, in some fixed cells the ECFP-tagged channel protein was
found in a perinuclear ring (Fig. 6, C and D),
which was not observed in live cells. The fluorescence amplification
used in the cells may have improved the resolution needed to see the
perinuclear localization or fixation and permeabilization may have
altered the channel protein distribution. This observation reinforces the usefulness of fluorescent probes that can be monitored in vivo, such as ECFP.
 |
DISCUSSION |
We have demonstrated a physical interaction between Kv4.2 channels
and PSD-95 heterologously expressed in mammalian cells, and we have
presented biochemical evidence that this interaction has functional
consequences: Kv4.2 becomes clustered and its surface expression
increases. Through mutation analysis, we showed that this association
requires the VSAL motif at the C terminus of the channel and
palmitoylation of PSD-95. Thus, VSAL can be added to the list of
PSD-95-binding motifs in proteins. VSAL is similar to the hydrophobic
PSD-95-binding motifs of some other Kv channels (Kv1.1, Kv1.2, and
Kv1.3) but with the terminal valine replaced with leucine. A terminal
leucine is important for PDZ binding in another ion channel: binding of
the cystic fibrosis transmembrane conductance regulator to
ezrin-radixin-moesin phosphoprotein 50 (40).
The increased cell surface expression of Kv4.2 in the presence of
PSD-95 could result from enhanced trafficking to the plasma membrane or
stabilization of Kv4.2 at the surface. Previous studies indicate that
PSD-95 suppresses internalization of
1-adrenergic receptors (41) and of Kv1.4 (15), another neuronal Kv channel, but one
that is mainly axonal in distribution. Unfortunately, the endocytosis
rate of Kv4.2 could not be determined using the methods applied to
Kv1.4 (biotinylation of an N-linked glycosylated residue) or
to the
1-adrenergic receptor (internalization of an
antibody bound to an external epitope). All currently available Kv4.2
antibodies label internal epitopes (this paper and Refs. 4, 6, 18, 38,
and 42) and Kv4.2 is not glycosylated (18). Nevertheless, the same
protein regions were critical for suppressing Kv1.4 endocytosis (15)
and for the PSD-95-mediated increase in Kv4.2 surface expression seen
in the present study, a C-terminal motif on the channel and
palmitoylation of PSD-95. Interestingly, some other proteins that
interact with Kv4.2 increase the current density, i.e. the
K+ channel interacting protein, KChIP (36), and filamin, a
cytoskeletal protein (43), raising the intriguing possibility that all
these interacting proteins increase expression at the cell surface. Alternatively, binding of the PDZ-containing PSD-95 protein might mask
an endoplasmic reticulum retention signal, as recently shown for
some NMDA receptors (44); however, this seems unlikely because channels
lacking the VSAL motif were expressed on the cell surface.
It is notable that PSD-95 can undergo redistribution in the presence of
interacting proteins in heterologous expression systems. PSD-95 is
diffusely distributed throughout the cytoplasm when expressed alone, as
demonstrated in this and several other studies (12, 14). However, when
co-expressed with Kv1.4, neuroligin, or
1-adrenergic
receptors, PSD-95 localization on the cell surface is greatly increased
(41, 45, 46). In our study a similar redistribution was also apparent
when PSD-95 and Kv4.2 were co-expressed, which suggests that each
protein can influence the distribution pattern of its interacting
partner. Interestingly, fixation of transfected cells, which was
required for immunofluorescent detection of PSD-95, abolished the
clustering observed in the live cells. This might explain why a
previous study (13) that examined Kv4.2 interactions with PSD-95 failed
to detect an association between these two proteins.
What physiological roles might there be for interaction between PSD-95
and Kv4.2? An obvious role is to establish or maintain specialized
channel distributions. In supraoptic neurons, Kv4.2 is clustered at the
post-synaptic membrane (47), particularly at sites of synaptic contact,
and in hippocampal neurons, where Kv4.2 is also present (3, 4, 18),
PSD-95 is only present in post-synaptic regions (48). Because Kv4.2 is
somatodendritic and we found that clustering of Kv4.2 was induced by
PSD-95 in transfected cells, it might also do so at the post-synaptic
membrane. PSD-95 clusters other proteins, including NMDA receptors (49) and Sema4C (50) in native tissues, and NMDA receptors (49, 51), Kir2.1
(52), Kir2.3 (52), and Kv1 channels (12) in heterologous expression
systems. The diverse types and distribution patterns of proposed
binding partners have been puzzling because PSD-95 was previously
thought to be concentrated at post-synaptic sites. However, a recent
examination of PSD-95 distribution using electron microscopy revealed a
surprisingly high amount in non-synaptic sites, for instance in axons
(53). Thus, in principle, PSD-95 might interact in vivo with
both somatodendritically located proteins, such as Kv4.2, and axonally
located proteins, such as some Kv1 channels.
Kv4.2 is increasingly implicated (3, 4, 18, 54, 55) as one molecular
correlate of the dendritic A-type K+ channel in pyramidal
hippocampal neurons, which regulates spike frequency through its
activity at sub-threshold membrane potentials (5, 56, 57) and controls
the amplitude and back propagation of action potentials (5). The
dendritic A-type K+ channel strongly influences the
induction of long term potentiation by NMDA receptors (5, 56, 57);
thus, it is significant that PSD-95 may position Kv4.2 close to NMDA
receptors where it can facilitate these functions.
Another important possibility is that PSD-95 influences the effect of
Kv4.2 on neuronal activity by forming complexes between Kv4.2 and
signaling molecules. Like many Kv channels, the biophysical properties
and activity of Kv4.2 are modified by diverse protein kinases (6, 38,
58). PSD-95 nucleates a macromolecular complex containing one of these
kinases, cAMP-dependent protein kinase, because it contains
a binding site for the protein kinase A-anchoring protein, AKAP79/150
(59). This interaction targets cAMP-dependent protein
kinase to excitatory synapses (60) to facilitate modulation of
NR2B-containing NMDA receptors (59). Multiprotein signaling complexes
containing Kv4.2 are likely to be key players in the modulation of
neuronal function. Although we did not detect a significant change in
current, PSD-95 affects Kv4.2 localization (increased cell surface
expression and clustering) and may thereby affect its post-insertional
modulation (by forming complexes with signaling molecules).
 |
ACKNOWLEDGEMENTS |
We are very grateful X.-P. Zhu for expert
technical assistance and to Dr. E. F. Stanley for advice and use
of the deconvolution microscope. We thank Dr. R. Khanna for helpful
comments on the manuscript and for earlier electrophysiology
experiments that are not included here.
 |
FOOTNOTES |
*
This work was supported in part by Canadian Institutes of
Health Grant MT13657, Heart and Stroke Foundation of Canada Grant T-3726 (to L. C. S.), and a Natural Sciences and Engineering Research Council grant (to O. T. J.). Parts of this work were previously published as abstracts (61, 62).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Supported by an Ontario Graduate Scholarship and a University
of Toronto Connaught Scholarship.
**
Supported by a National Science Foundation Graduate Student Fellowship.

Current address: Division of Neuroscience, School of Biological
Sciences, University of Manchester, Manchester M13 9PT, UK.
§§
To whom correspondence should be addressed: MC9-415, Toronto
Western Hospital, 399 Bathurst St., Toronto, Ontario M5T 2S8, Canada. Tel.: 416-603-5800, ext. 2052; Fax: 416-603-5745;
E-mail: schlicht@uhnres.utoronto.ca.
Published, JBC Papers in Press, March 28, 2002, DOI 10.1074/jbc.M109412200
2
P. Backx, personal communication.
 |
ABBREVIATIONS |
The abbreviations used are:
Kv, voltage-gated
K+ channel;
C-Kv4.2, ECFP-tagged Kv4.2;
HEK, human
embryonic kidney cells;
tsA201, human embryonic kidney cells expressing
the large T antigen;
IP, immunoprecipitation;
PBS, phosphate-buffered
saline;
CHO, Chinese hamster ovary;
GFP, green fluorescent protein;
VSAL, Val-Ser-Ala-Leu;
ECFP, enhanced cyan fluorescent protein;
NMDA, N-methyl-D-aspartic acid.
 |
REFERENCES |
| 1.
|
Chandy, K. G.,
and Gutman, G. A.
(1995)
in
Ligand- and Voltage-gated Ion Channels
(North, R. A., ed)
, pp. 1-71, CRC Press, Inc., Boca Raton, FL
|
| 2.
|
Xu, H., Li, H.,
and Nerbonne, J. M.
(1999)
J. Physiol. (Lond.)
519,
11-21[Abstract/Free Full Text]
|
| 3.
|
Maletic-Savatic, M.,
Lenn, N. J.,
and Trimmer, J. S.
(1995)
J. Neurosci.
15,
3840-3851[Abstract]
|
| 4.
|
Sheng, M.,
Tsaur, M. L.,
Jan, Y. N.,
and Jan, L. Y.
(1992)
Neuron
9,
271-284[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Hoffman, D. A.,
Magee, J. C.,
Colbert, C. M.,
and Johnston, D.
(1997)
Nature
387,
869-875[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Adams, J. P.,
Anderson, A. E.,
Varga, A. W.,
Dineley, K. T.,
Cook, R. G.,
Pfaffinger, P. J.,
and Sweatt, J. D.
(2000)
J. Neurochem.
75,
2277-2287[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Zito, K.,
Fetter, R. D.,
Goodman, C. S.,
and Isacoff, E. Y.
(1997)
Neuron
19,
1007-1016[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Arnold, D. B.,
and Clapham, D. E.
(1999)
Neuron
23,
149-157[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Cooper, E. C.,
Milroy, A.,
Jan, Y. N.,
Jan, L. Y.,
and Lowenstein, D. H.
(1998)
J. Neurosci.
18,
965-974[Abstract/Free Full Text]
|
| 10.
|
Debanne, D.,
Guerineau, N. C.,
Gahwiler, B. H.,
and Thompson, S. M.
(1997)
Nature
389,
286-289[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Jackson, M. B.,
Konnerth, A.,
and Augustine, G. J.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
380-384[Abstract/Free Full Text]
|
| 12.
|
Kim, E.,
and Sheng, M.
(1996)
Neuropharmacology
35,
993-1000[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Kim, E.,
Niethammer, M.,
Rothschild, A.,
Jan, Y. N.,
and Sheng, M.
(1995)
Nature
378,
85-88[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Tiffany, A. M.,
Manganas, L. N.,
Kim, E.,
Hsueh, Y. P.,
Sheng, M.,
and Trimmer, J. S.
(2000)
J. Cell Biol.
148,
147-158[Abstract/Free Full Text]
|
| 15.
|
Jugloff, D. G.,
Khanna, R.,
Schlichter, L. C.,
and Jones, O. T.
(2000)
J. Biol. Chem.
275,
1357-1364[Abstract/Free Full Text]
|
| 16.
|
Li, D.,
Takimoto, K.,
and Levitan, E. S.
(2000)
J. Biol. Chem.
275,
11597-11602[Abstract/Free Full Text]
|
| 17.
|
Fujita, A.,
and Kurachi, Y.
(2000)
Biochem. Biophys. Res. Commun.
269,
1-6[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Baldwin, T. J.,
Tsaur, M. L.,
Lopez, G. A.,
Jan, Y. N.,
and Jan, L. Y.
(1991)
Neuron
7,
471-483[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Khanna, R.,
Myers, M. P.,
Laine, M.,
and Papazian, D. M.
(2001)
J. Biol. Chem.
276,
34028-34034[Abstract/Free Full Text]
|
| 20.
|
Kingston, R. E.,
Chen, C. A.,
Okayama, H.,
and Rose, J. K.
(2001)
in
Current Protocols in Molecular Biology
(Ausubel, F. M.
, et al., eds), Vol. 2
, pp. 9.1.4-9.1.11, John Wiley & Sons, Inc., Boston
|
| 21.
|
Khanna, R.,
Chang, M. C.,
Joiner, W. J.,
Kaczmarek, L. K.,
and Schlichter, L. C.
(1999)
J. Biol. Chem.
274,
14838-14849[Abstract/Free Full Text]
|
| 22.
|
Johns, D. C.,
Nuss, H. B.,
and Marban, E.
(1997)
J. Biol. Chem.
272,
31598-31603[Abstract/Free Full Text]
|
| 23.
|
Wickenden, A. D.,
Jegla, T. J.,
Kaprielian, R.,
and Backx, P. H.
(1999)
Am. J. Physiol.
276,
H1599-H1607
|
| 24.
|
Nishiyama, A.,
Ishii, D. N.,
Backx, P. H.,
Pulford, B. E.,
Birks, B. R.,
and Tamkun, M. M.
(2001)
Am. J. Physiol.
281,
H1800-H1807[Abstract/Free Full Text]
|
| 25.
|
Martens, J. R.,
Navarro-Polanco, R.,
Coppock, E. A.,
Nishiyama, A.,
Parshley, L.,
Grobaski, T. D.,
and Tamkun, M. M.
(2000)
J. Biol. Chem.
275,
7443-7446[Abstract/Free Full Text]
|
| 26.
|
Jones, O. T.,
Bernstein, G. M.,
Jones, E. J.,
Jugloff, D. G.,
Law, M.,
Wong, W.,
and Mills, L. R.
(1997)
J. Neurosci.
17,
6152-6164[Abstract/Free Full Text]
|
| 27.
|
Roquemore, E. P.,
and Banting, G.
(1998)
Mol. Biol. Cell
9,
2125-2144[Abstract/Free Full Text]
|
| 28.
|
Kuryshev, Y. A.,
Wible, B. A.,
Gudz, T. I.,
Ramirez, A. N.,
and Brown, A. M.
(2001)
Am. J. Physiol.
281,
C290-C299[Abstract/Free Full Text]
|
| 29.
|
Hsueh, Y. P.,
and Sheng, M.
(1999)
J. Biol. Chem.
274,
532-536[Abstract/Free Full Text]
|
| 30.
|
Zar, J. H.
(1974)
Biostatistical Analysis
, pp. 185-186, Prentice-Hall, Inc., Englewood Cliffs, NJ
|
| 31.
|
Zhu, G.,
Zhang, Y., Xu, H.,
and Jiang, C.
(1998)
J. Neurosci. Methods
81,
73-83[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Petersen, K. R.,
and Nerbonne, J. M.
(1999)
Pfluegers Arch.
437,
381-392[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Bahring, R.,
Boland, L. M.,
Varghese, A.,
Gebauer, M.,
and Pongs, O.
(2001)
J. Physiol. (Lond.)
535,
65-81[Abstract/Free Full Text]
|
| 34.
|
Jerng, H. H.,
and Covarrubias, M.
(1997)
Biophys. J.
72,
163-174[Abstract/Free Full Text]
|
| 35.
|
Nakamura, T. Y.,
Pountney, D. J.,
Ozaita, A.,
Nandi, S.,
Ueda, S.,
Rudy, B.,
and Coetzee, W. A.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
12808-12813[Abstract/Free Full Text]
|
| 36.
|
An, W. F.,
Bowlby, M. R.,
Betty, M.,
Cao, J.,
Ling, H. P.,
Mendoza, G.,
Hinson, J. W.,
Mattsson, K. I.,
Strassle, B. W.,
Trimmer, J. S.,
and Rhodes, K. J.
(2000)
Nature
403,
553-556[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Yeola, S. W.,
and Snyders, D. J.
(1997)
Cardiovasc. Res.
33,
540-547[Abstract/Free Full Text]
|
| 38.
|
Anderson, A. E.,
Adams, J. P.,
Qian, Y.,
Cook, R. G.,
Pfaffinger, P. J.,
and Sweatt, J. D.
(2000)
J. Biol. Chem.
275,
5337-5346[Abstract/Free Full Text]
|
| 39.
|
Nakamura, T. Y.,
Nandi, S.,
Pountney, D. J.,
Artman, M.,
Rudy, B.,
and Coetzee, W. A.
(2001)
FEBS Lett.
499,
205-209[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Moyer, B. D.,
Duhaime, M.,
Shaw, C.,
Denton, J.,
Reynolds, D.,
Karlson, K. H.,
Pfeiffer, J.,
Wang, S.,
Mickle, J. E.,
Milewski, M.,
Cutting, G. R.,
Guggino, W. B., Li, M.,
and Stanton, B. A.
(2000)
J. Biol. Chem.
275,
27069-27074[Abstract/Free Full Text]
|
| 41.
|
Hu, L. A.,
Tang, Y.,
Miller, W. E.,
Cong, M.,
Lau, A. G.,
Lefkowitz, R. J.,
and Hall, R. A.
(2000)
J. Biol. Chem.
275,
38659-38666[Abstract/Free Full Text]
|
| 42.
|
Takeuchi, S.,
Takagishi, Y.,
Yasui, K.,
Murata, Y.,
Toyama, J.,
and Kodama, I.
(2000)
J. Mol. Cell. Cardiol.
32,
1361-1369[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Petrecca, K.,
Miller, D. M.,
and Shrier, A.
(2000)
J. Neurosci.
20,
8736-8744[Abstract/Free Full Text]
|
| 44.
|
Standley, S.,
Roche, K. W.,
McCallum, J.,
Sans, N.,
and Wenthold, R. J.
(2000)
Neuron
28,
887-898[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Irie, M.,
Hata, Y.,
Takeuchi, M.,
Ichtchenko, K.,
Toyoda, A.,
Hirao, K.,
Takai, Y.,
Rosahl, T. W.,
and Sudhof, T. C.
(1997)
Science
277,
1511-1515[Abstract/Free Full Text]
|
| 46.
|
Burke, N. A.,
Takimoto, K., Li, D.,
Han, W.,
Watkins, S. C.,
and Levitan, E. S.
(1999)
J. Gen. Physiol.
113,
71-80[Abstract/Free Full Text]
|
| 47.
|
Alonso, G.,
and Widmer, H.
(1997)
Neuroscience
77,
617-621[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
El-Husseini, A. E.,
Craven, S. E.,
Chetkovich, D. M.,
Firestein, B. L.,
Schnell, E.,
Aoki, C.,
and Bredt, D. S.
(2000)
J. Cell Biol.
148,
159-172[Abstract/Free Full Text]
|
| 49.
|
Kornau, H. C.,
Schenker, L. T.,
Kennedy, M. B.,
and Seeburg, P. H.
(1995)
Science
269,
1737-1740[Abstract/Free Full Text]
|
| 50.
|
Inagaki, S.,
Ohoka, Y.,
Sugimoto, H.,
Fujioka, S.,
Amazaki, M.,
Kurinami, H.,
Miyazaki, N.,
Tohyama, M.,
and Furuyama, T.
(2001)
J. Biol. Chem.
276,
9174-9181[Abstract/Free Full Text]
|
| 51.
|
Niethammer, M.,
Kim, E.,
and Sheng, M.
(1996)
J. Neurosci.
16,
2157-2163[Abstract/Free Full Text]
|
| 52.
|
Nehring, R. B.,
Wischmeyer, E.,
Doring, F.,
Veh, R. W.,
Sheng, M.,
and Karschin, A.
(2000)
J. Neurosci.
20,
156-162[Abstract/Free Full Text]
|
| 53.
|
Aoki, C.,
Miko, I.,
Oviedo, H.,
Mikeladze-Dvali, T.,
Alexandre, L.,
Sweeney, N.,
and Bredt, D. S.
(2001)
Synapse
40,
239-257[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Serodio, P.,
Kentros, C.,
and Rudy, B.
(1994)
J. Neurophysiol.
72,
1516-1529[Abstract/Free Full Text]
|
| 55.
|
Serodio, P.,
and Rudy, B.
(1998)
J. Neurophysiol.
79,
1081-1091[Abstract/Free Full Text]
|
| 56.
|
Magee, J.,
Hoffman, D.,
Colbert, C.,
and Johnston, D.
(1998)
Annu. Rev. Physiol.
60,
327-346[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Hoffman, D. A.,
and Johnston, D.
(1998)
J. Neurosci.
18,
3521-3528[Abstract/Free Full Text]
|
| 58.
| Varga, A. W., Anderson, A. E., Adams, J. P., Sweatt,
J. D., Whitson, B. S., and Sweatt, J. D. (2000) in
Proceedings 30th Annual Meeting of the Society for Neuroscience,
November 4-9, New Orleans
|
| 59.
|
Colledge, M.,
Dean, R. A.,
Scott, G. K.,
Langeberg, L. K.,
Huganir, R. L.,
and Scott, J. D.
(2000)
Neuron
27,
107-119[CrossRef][Medline]
[Order article via Infotrieve]
|
| 60.
|
Carr, D. W.,
Stofko-Hahn, R. E.,
Fraser, I. D.,
Cone, R. D.,
and Scott, J. D.
(1992)
J. Biol. Chem.
267,
16816-16823[Abstract/Free Full Text]
|
| 61.
|
Wong, W.,
Khanna, R.,
Jugloff, D. G. M.,
Jones, O. T.,
and Schlichter, L. C.
(2000)
Mol. Biol. Cell
12,
222
|
| 62.
|
Wong, W.,
Khanna, R.,
Jugloff, D. G. M.,
Jones, O. T.,
and Schlichter, L. C.
(2002)
Biophys. J.
82,
253
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
